Al-Marzooqi Fahed 4

What Happened

• Fahed Al‑Marzooqi, a director of vTv Therapeutics Inc. (VTVT), was granted a derivative award on June 26, 2026: an option or similar equity award covering 6,000 shares at a grant price of $35.08 per share, with a total grant value of $210,480. The filing lists this as an acquisition/award (transaction code A).

Key Details

• Transaction date: 2026-06-26; Form 4 filed: 2026-06-29 (appears timely; Form 4s are generally due within two business days).
• Grant details: 6,000 shares, grant price $35.08, aggregate value $210,480; reported as a derivative award.
• Vesting/conditions: See footnote — vests on the earlier of June 26, 2027, and the date of the 2027 annual meeting, subject to continued board service.
• Shares owned after transaction: not specified in the excerpt provided.
• Transaction code: A = Award/Grant (derivative).

Context

• This was a compensation grant to a board member (not a sale). The award is a derivative grant that vests over time and is common for director compensation; it does not indicate any immediate sale of shares. No 10b5-1 plan, tax withholding, or other special conditions were reported in the provided excerpt.